It is also noteworthy that the expression levels of both the PDGFR and epidermal growth factor receptor (EGFR) are significantly increased in the vasculature of SSc-PAH patients compared to controls [12]. The gene discussed is PDGFRB; the disease is pulmonary arterial hypertension.